메뉴 건너뛰기




Volumn 8, Issue 3, 1999, Pages 197-205

Safety profile of nicorandil - Prescription-event monitoring (PEM) study

Author keywords

Adverse drug reactions; Event rates; General practice; Nicorandil; Prescription event monitoring study

Indexed keywords

CORONARY VASODILATING AGENT; NICORANDIL;

EID: 0033031689     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199905/06)8:3<197::AID-PDS422>3.0.CO;2-T     Document Type: Article
Times cited : (32)

References (10)
  • 1
    • 0028001085 scopus 로고
    • Guidelines for company-sponsored safety assessment of marketed medicines (SAMM Guidelines)
    • Medicines Control Agency, Committee on Safety of Medicines, Royal College of General Practitioners, British Medical Association and Association of the Pharmaceutical Industry. Guidelines for company-sponsored safety assessment of marketed medicines (SAMM Guidelines). Br. J. Clin. Pharmacol. 1994; 38: 95-97.
    • (1994) Br. J. Clin. Pharmacol. , vol.38 , pp. 95-97
  • 2
    • 0029863121 scopus 로고    scopus 로고
    • Salmeterol: A study by Prescription Event Monitoring in a UK cohort of 15,407 patients
    • Mann, R. D., Kubota, K., Pearce, G. L. and Wilton, L. V. Salmeterol: a study by Prescription Event Monitoring in a UK cohort of 15,407 patients. J. Clin. Epidemiol. 1996; 49: 247-250.
    • (1996) J. Clin. Epidemiol. , vol.49 , pp. 247-250
    • Mann, R.D.1    Kubota, K.2    Pearce, G.L.3    Wilton, L.V.4
  • 3
    • 0029867403 scopus 로고    scopus 로고
    • A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies
    • Wilton, L. V., Pearce, G. L. and Mann, R. D. A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. Br. J. Clin. Pharmacol. 1996; 41: 277-284.
    • (1996) Br. J. Clin. Pharmacol. , vol.41 , pp. 277-284
    • Wilton, L.V.1    Pearce, G.L.2    Mann, R.D.3
  • 4
    • 0030423280 scopus 로고    scopus 로고
    • The safety of finasteride used in benign prostatic hypertophy: A non-interventional observational cohort study in 14,772 patients
    • Wilton, L., Pearce, G., Edet, E., Freemantle, S., Stephens, M. D. B. and Mann, R. D. The safety of finasteride used in benign prostatic hypertophy: a non-interventional observational cohort study in 14,772 patients. Br. J. Urol. 1996; 78: 379-384.
    • (1996) Br. J. Urol. , vol.78 , pp. 379-384
    • Wilton, L.1    Pearce, G.2    Edet, E.3    Freemantle, S.4    Stephens, M.D.B.5    Mann, R.D.6
  • 6
    • 2442756512 scopus 로고    scopus 로고
    • Data sheet Ikorel (nicorandil, Rhône-Poulenc Rorer), 1996
    • Data sheet Ikorel (nicorandil, Rhône-Poulenc Rorer), 1996.
  • 10
    • 0023925775 scopus 로고
    • Spontaneous reporting of adverse drug reactions
    • Rawlins, M. D. Spontaneous reporting of adverse drug reactions. Br. J. Clin. Pharmacol. 1988; 26:1-5, 7-11.
    • (1988) Br. J. Clin. Pharmacol. , vol.26 , pp. 1-5
    • Rawlins, M.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.